People: Abaxis Inc (ABAX.OQ)

ABAX.OQ on NASDAQ Stock Exchange Global Select Market

39.39USD
3:31pm EDT
Price Change (% chg)

$0.18 (+0.46%)
Prev Close
$39.21
Open
$39.00
Day's High
$39.52
Day's Low
$38.76
Volume
26,916
Avg. Vol
72,277
52-wk High
$51.80
52-wk Low
$32.11

Search Stocks

Summary

Name Age Since Current Position

Clinton Severson

64 1998 Chairman of the Board, President, Chief Executive Officer

Alberto Santa Ines

66 2002 Chief Financial Officer, Vice President - Finance

Donald Wood

61 2009 Chief Operations Officer

Kenneth Aron

60 2008 Chief Technology Officer

Vladimir Ostoich

67 Vice President - Marketing for Pacific Rim, Vice President - Government Affairs

Achim Henkel

55 2008 Managing Director of Abaxis Europe GmbH

Vernon Altman

67 2011 Independent Director

Richard Bastiani

70 1995 Independent Director

Michael Casey

67 2010 Independent Director

Henk Evenhuis

70 2002 Independent Director

Prithipal Singh

74 1992 Independent Director

Biographies

Name Description

Clinton Severson

Mr. Clinton H. Severson is Chairman of the Board, President and Chief Executive Officer of Abaxis Inc. He has served as the company's President, Chief Executive Officer and one of the directors since June 1996. He was appointed Chairman of the Board in May 1998. Since June 2011, Mr. Severson served on the Board of Directors of Response Biomedical Corporation (CDNX: RBM). Since November 2008, Mr. Severson served on the Board of Directors of Trinity Biotech (Nasdaq: TRIB), a biotechnology company. From November 2006 to February 2012, Mr. Severson served on the Board of Directors of CytoCore, Inc. (OTCBB: CYOE.OB), a biotechnology company. From February 1989 to May 1996, Mr. Severson served as President and Chief Executive Officer of MAST Immunosystems, Inc., a privately-held medical diagnostic company. Mr. Severson is also a member of the board of directors of a privately-held company.

Alberto Santa Ines

Mr. Alberto R. Santa Ines is Chief Financial Officer, Vice President - Finance of Abaxis Inc. Mr. Santa Ines joined the company in February 2000 as Finance Manager. In April 2001, Mr. Santa Ines was promoted to Interim Chief Financial Officer and Director of Finance, and in April 2002, he was promoted to his current position. From March 1998 to January 2000, Mr. Santa Ines was a self-employed consultant to several companies. From August 1997 to March 1998, Mr. Santa Ines was the Controller of Unisil (Pink Sheets: USIL), a semiconductor company. From April 1994 to August 1997, he was a Senior Finance Manager at Lam Research Corporation (Nasdaq: LRCX), a semiconductor equipment manufacturer.

Donald Wood

Mr. Donald Peter Wood is Chief Operations Officer of Abaxis Inc. Mr. Wood joined the company in October 2007 as Vice President of Operations. From April 2003 to September 2007, Mr. Wood was the Vice President of Operations of Cholestech Corporation (Nasdaq: CTEC), a medical products manufacturing company that was subsequently acquired by Inverness Medical Innovations, Inc. in September 2007. From July 2001 to March 2003, Mr. Wood served as Vice President of Bone Health, a business unit of Quidel Corporation, a manufacturing and marketer of point-of-care diagnostics, and was responsible for Bone Health Product Operations, Device Research and Development, and Sales and Marketing. He also served as Quidel’s Vice President of Ultrasound Operations from August 1999 to July 2001. Prior to joining Quidel, Mr. Wood was the Director of Ultrasound Operations for Metra Biosystems Inc., a developer and manufacturing company of point-of-care products for osteoporosis, from July 1998 to August 1999 prior to Quidel’s acquisition of Metra Biosystems Inc.

Kenneth Aron

Dr. Kenneth P. Aron, Ph.D., is Chief Technology Officer of Abaxis Inc. Dr. Aron joined the company in February 2000 as Vice President of Research and Development. From April 1998 to November 1999, Dr. Aron was Vice President of Engineering and Technology of Incyte Pharmaceuticals (Nasdaq: INCY), a genomic information company. From April 1996 to April 1998, Dr. Aron was Vice President of Research, Development and Engineering for Cardiogenesis Corporation (Nasdaq: CGCP), a manufacturer of laser-based cardiology surgical products.

Vladimir Ostoich

Dr. Vladimir E. Ostoich Ph.D., is Vice President - Marketing for Pacific Rim, Vice President - Government Affairs of Abaxis Inc. Dr. Ostoich has served as Vice President in various capacities at Abaxis since inception, including as Vice President of Research and Development, Senior Vice President of Research and Development, Vice President of Engineering and Instrument Manufacturing and Vice President of Marketing and Sales for the United States and Canada.

Achim Henkel

Mr. Achim Henkel is Managing Director of Abaxis Europe GmbH, a subsidiary of Abaxis Inc. Mr. Henkel joined the company in January 1998 as a consultant to build a European distribution network. From January 2000 to June 2008, Mr. Henkel was Sales and Marketing Manager for Europe, the Middle East and Africa. From October 1996 to December 1997, Mr. Henkel was a self-employed consultant to several companies. From January 1988 to September 1996, Mr. Henkel held a number of positions with Syva Diagnostics Germany, including as National Sales Manager from 1991 until Syva was acquired by a subsidiary of Hoechst AG in 1995. From 1982 to 1987, Mr. Henkel was regional sales manager for Hoechst AG, a German pharmaceutical company.

Vernon Altman

Mr. Vernon Edward Altman is Independent Director of Abaxis Inc. Mr. Altman joined the founding group to start Bain & Company, a global business consulting firm, in 1973 and is currently Senior Advisor of Bain & Company. Mr. Altman is Chairman of the Board of Directors of Vobile, Inc., a company focused on content protection and monetization for media companies and other digital media stakeholders. He also served on the Board of Directors of Napster, Inc. prior to its acquisition.

Richard Bastiani

Dr. Richard J. Bastiani, Ph.D., is Independent Director of Abaxis Inc. Dr. Bastiani is currently retired. From 2007 to 2011, Dr. Bastiani served as Chairman of the Board of Directors of Response Biomedical Corporation (CDNX: RBM). From 1998 to 2005, Dr. Bastiani served as Chairman of the Board of Directors of ID Biomedical Corporation (Nasdaq: IDBE), after he was appointed to the Board of Directors of ID Biomedical Corporation in October 1996. Dr. Bastiani was President of Dendreon (Nasdaq: DNDN), a biotechnology company, from September 1995 to September 1998. From 1971 until 1995, Dr. Bastiani held a number of positions with Syva Company, a diagnostic company, including as President from 1991 until Syva was acquired by a subsidiary of Hoechst AG of Germany in 1995. Dr. Bastiani is also a member of the board of directors of two privately-held companies.

Michael Casey

Mr. Michael D. Casey is Independent Director of Abaxis Inc. Mr. Casey is currently retired. From September 1997 to February 2002, Mr. Casey served as the Chairman, President, Chief Executive Officer and a director of Matrix Pharmaceutical, Inc. From November 1995 to September 1997, Mr. Casey was Executive Vice President at Schein Pharmaceutical, Inc. (NYSE: SHP). In December 1996, he was appointed President of the retail and specialty products division of Schein Pharmaceutical. From June 1993 to November 1995, he served as President and Chief Operating Officer of Genetic Therapy, Inc. Mr. Casey was President of McNeil Pharmaceutical (a unit of Johnson & Johnson) from 1989 to June 1993 and Vice President, Sales and Marketing for Ortho Pharmaceutical Corp. (a subsidiary of Johnson & Johnson) from 1985 to 1989. Mr. Casey has served on the Board of Directors of Celgene Corporation (Nasdaq: CELG) since 2002 and Durect Corp. (Nasdaq: DRRX) since 2004. Mr. Casey previously served on the Board of Directors of AVI Biopharma, Inc. (Nasdaq: AVII) from 2006 to 2010, Allos Therapeutics, Inc. (Nasdaq: ALTH) from 2002 to 2010, Cholestech Corporation (Nasdaq: CTEC) from 2001 to 2007, OrthoLogic Corporation (Nasdaq: OLGC) from 2004 to 2007, Sicor, Inc. (Nasdaq: SCRI) from 2002 to 2004 and Bone Care International, Inc. (Nasdaq: BCII) from 2001 to 2005.

Henk Evenhuis

Mr. Henk J. Evenhuis is Independent Director of Abaxis Inc. Mr. Evenhuis is currently retired. He served on the Board of Directors of Credence Systems Corporation (Nasdaq: CMOS), a semiconductor equipment manufacturer, from 1993 to 2008. Mr. Evenhuis served as Executive Vice President and Chief Financial Officer of Fair Isaac Corporation (NYSE: FIC), a global provider of analytic software products to the financial services, insurance and health care industries from October 1999 to October 2002. From 1987 to 1998, he was Executive Vice President and Chief Financial Officer of Lam Research Corporation (Nasdaq: LRCX), a semiconductor equipment manufacturer.

Prithipal Singh

Dr. Prithipal Singh, Ph.D., is Independent Director of Abaxis Inc. Prior to retiring, Dr. Singh was the Founder, Chairman and Chief Executive Officer of ChemTrak Inc. (Pink Sheets: CMTR) from 1988 to 1998. Prior to this, Dr. Singh was an Executive Vice President of Idetec Corporation from 1985 to 1988 and a Vice President of Syva Corporation from 1977 to 1985.

Basic Compensation

Name Fiscal Year Total

Clinton Severson

2,040,840

Alberto Santa Ines

1,040,020

Donald Wood

1,047,980

Kenneth Aron

1,055,950

Vladimir Ostoich

1,050,050

Achim Henkel

--

Vernon Altman

--

Richard Bastiani

--

Michael Casey

--

Henk Evenhuis

--

Prithipal Singh

--
As Of 30 Mar 2013

Options Compensation

Name Options Value

Clinton Severson

814,000 14,314,043

Alberto Santa Ines

194,000 3,283,750

Donald Wood

0 0

Kenneth Aron

284,500 3,488,000

Vladimir Ostoich

289,500 4,532,200

Achim Henkel

0 0

Vernon Altman

0 0

Richard Bastiani

0 0

Michael Casey

0 0

Henk Evenhuis

0 0

Prithipal Singh

0 0
Search Stocks